Semaglutide Tirzepatide เปปไทด์ลดน้ำหนัก CAS: 2023788-19-2
สินค้าใหม่
1 บาท
Product Description
High Purity Tirzepatide Raw Powder CAS 2023788-19-2
Detailed Product Information
Product Name :Tirzepatide
Trade Name: M ounjaro
CAS No.:2023788-19-2
Purity : 98% HPLC
Appearance: Lyophilized Powder
Typical use: weight loss peptides
Shelf Life :2 years
Storage:Refrigeration keep dry and away from light.
Description:
Tirzepatide is a novel, once weekly, dual GIP/GLP-1 receptor agonist and is under development for the treatment of type 2 diabetes (T2D) and obesity.
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide-GLP-1 receptor agonist. Its structure is primarily based on the glucose-dependent insulinotropic polypeptide amino acid sequence and includes a C20 fatty diacid moiety. Its half-life of approximately 5 days allows once-weekly subcutaneous administration. A phase 2b trial involving patients with type 2 diabetes showed that those who received tirzepatide had dose-dependent reductions in the glycated hemoglobin level and weight at 26 weeks.
Once-weekly injectable semaglutide, a selective GLP-1 receptor agonist, is approved for the treatment of type 2 diabetes at doses up to 1 mg. In trials involving patients who received semaglutide, the mean reductions in the glycated hemoglobin level have been reported to be as high as 1.8 percentage points and the mean reductions in body weight have been reported to be as high as 6.5 kg.
We conducted the SURPASS-2 trial (A Study of Tirzepatide [LY3298176] versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants with Type 2 Diabetes) to compare the efficacy and safety of tirzepatide at doses of 5 mg, 10 mg, and 15 mg with those of semaglutide at a dose of 1 mg in patients with type 2 diabetes that had been inadequately controlled with metformin monotherapy.
R ybelsus (semaglutide) is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus.
R ybelsus is usually given after other diabetes medicines have been tried without success.
The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press release.
Weekly semaglutide 2.4 mg (W egovy, Novo Nordisk), a GLP-1 receptor agonist, is the first-approved drug for chronic weight management in adults with general obesity or overweight since 2014. Semaglutide is indicated for chronic weight management in adults with a BMI of 27 kg/m² or greater who have at least one weight-related comorbidity, such as type 2 diabetes or hypertension, or in adults with a BMI of at least 30 kg/m²
Semaglutide 1 mg injection (O-zempic) was first approved as a treatment for type 2 diabetes in 2017.
Safety and efficacy of semaglutide 2.4 mg was assessed in four 68-week trials. Three were randomized, double-blind, placebo-controlled trials, including 16 weeks of dose increases, and one was a double-blind, placebo-controlled, randomized withdrawal trial in which patients assigned semaglutide either continued treatment or switched to a placeboSemaglutide 2.4 mg should not be used in combination with other semaglutide-containing products, other GLP-1 receptor agonists or other products intended for weight loss, including prescription drugs, over-the-counter drugs and herbal products, according to the release. Semaglutide 2.4 mg has not been studied in patients with a history of pancreatitis.
This is a once-weekly injectable, which is more tolerable way of managing obesity vs. other treatments. The STEP study data showed semaglutide 2.4 mg crosses the magic threshold of 10% weight loss for many people who received it. This is another tool that will allow clinicians to better manage obesity.
HOT SELLING
CAS | Common Name |
910463-68-2 | Semaglutide acetate salt |
2023788-19-2 | Tirzepatide |
28578-16-7 | PMK ethyl glycidate |
20320-59-6 | Diethyl(phenylacetyl)malonate |
288573-56-8 | tert-butyl 4-(4-fluoroanilino)piperidine-1-carboxylate |
236117-38-7 | 2-iodo-1-p-tolylpropan-1-one |
102-97-6 | Benzylisopropylamine |
52190-28-0 | 2-Bromo-3',4'-(methylenedioxy)p-ropiophenone |
2114-39-8 | 2-bromo-1-phenylpropane |
23076-35-9 | Xylazine hydrochloride |
5061-21-2 | 3-Bromdihydrofuran-2(3H)-on |
59-67-6 | Nicotinic acid |
50-56-6 | Oxytocin acetate salt |
132112-35-7 | Ropivacaine hydrochloride |
Company information
Our customers are all over the world, mainly selling in the United States, Canada, Australia, the United Kingdom, the Netherlands, Germany, France and other EU countries, Southeast Asia, South America, and Oceania. We also have many customers.
Our business is based on honesty and mutual trust. Sincerely look forward to establishing long-term mutually beneficial business relationships with customers around the world.
Certificate
Exhibition
Packing & Shipping
Payment
FAQ
Q: How to start orders or make payments?
A:You can send our your Purchase order(if your company has), or just send a simple confirmation by email or by Trade Manager, and we will send you Proforma Invoice with our bank details for your confirmation, then you can make payment accordingly.
Q: How to confirm the Product Quality before placing orders?
A:You can get free samples for some products,you only need to pay the shipping cost or arrange a courier to us and take the samples. You can send us your product specifications and requests,we will manufacture the products according to your requests.
Q: What's your MOQ?
A:For the high value product, our MOQ starts from 1g and generally starts from 10gs. For other low price product, our MOQ starts from 100g and 1kg.
Q: Is there a discount?
A: Yes, for larger quantity, we always support with better price.
Q:How do you treat quality complaint?
First of all, our quality control will reduce the quality problem to near zero. If there is a quality problem caused by us, we will send you free goods for replacement or refund your loss.
Q:How to contact us ?
You can choose your interested products and send inquiry to us.
You can dial our telephone directly, you will get our reply.